• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高成人骨髓移植患者微生物组研究粪便收集率的经济激励措施。

Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients.

机构信息

Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina, United States of America.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, United States of America.

出版信息

PLoS One. 2022 May 4;17(5):e0267974. doi: 10.1371/journal.pone.0267974. eCollection 2022.

DOI:10.1371/journal.pone.0267974
PMID:35507633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067695/
Abstract

INTRODUCTION

In order to study the role of the microbiome in hematopoietic stem cell transplantation (HCT), researchers collect stool samples from patients at various time points throughout HCT. However, stool collection requires active subject participation and may be limited by patient reluctance to handling stool.

METHODS

We performed a prospective study on the impact of financial incentives on stool collection rates. The intervention group consisted of allogeneic HCT patients from 05/2017-05/2018 who were compensated with a $10 gas gift card for each stool sample. The intervention group was compared to a historical control group of allogeneic HCT patients from 11/2016-05/2017 who provided stool samples before the incentive was implemented. To control for possible changes in collections over time, we also compared a contemporaneous control group of autologous HCT patients from 05/2017-05/2018 with a historical control group of autologous HCT patients from 11/2016-05/2017; neither autologous HCT group was compensated. The collection rate was defined as the number of samples provided divided by the number of time points we attempted to obtain stool.

RESULTS

There were 35 allogeneic HCT patients in the intervention group, 19 allogeneic HCT patients in the historical control group, 142 autologous HCT patients in the contemporaneous control group (that did not receive a financial incentive), and 75 autologous HCT patients in the historical control group. Allogeneic HCT patients in the intervention group had significantly higher average overall collection rates when compared to the historical control group allogeneic HCT patients (80% vs 37%, p<0.0001). There were no significant differences in overall average collection rates between the autologous HCT patients in the contemporaneous control and historical control groups (36% vs 32%, p = 0.2760).

CONCLUSION

Our results demonstrate that a modest incentive can significantly increase collection rates. These results may help to inform the design of future studies involving stool collection.

摘要

简介

为了研究微生物组在造血干细胞移植(HCT)中的作用,研究人员在 HCT 过程中的各个时间点从患者收集粪便样本。然而,粪便采集需要患者的积极参与,并且可能因患者不愿处理粪便而受到限制。

方法

我们进行了一项关于经济激励对粪便采集率影响的前瞻性研究。干预组由 2017 年 5 月至 2018 年 5 月期间接受异基因 HCT 的患者组成,每位患者每提供一份粪便样本可获得 10 美元的加油卡作为补偿。干预组与在实施激励措施之前提供粪便样本的 2016 年 11 月至 2017 年 5 月期间接受异基因 HCT 的历史对照组进行比较。为了控制随时间采集量可能发生的变化,我们还将 2017 年 5 月至 2018 年 5 月期间接受自体 HCT 的同期对照组与 2016 年 11 月至 2017 年 5 月期间接受自体 HCT 的历史对照组进行比较;两个自体 HCT 组均未获得补偿。采集率定义为提供的样本数除以我们尝试采集粪便的时间点数。

结果

干预组有 35 例异基因 HCT 患者,历史对照组有 19 例异基因 HCT 患者,同期对照组(未获得经济激励)有 142 例自体 HCT 患者,历史对照组有 75 例自体 HCT 患者。与历史对照组的异基因 HCT 患者相比,干预组的异基因 HCT 患者的总体平均采集率显著更高(80%比 37%,p<0.0001)。同期对照组和历史对照组的自体 HCT 患者的总体平均采集率无显著差异(36%比 32%,p = 0.2760)。

结论

我们的结果表明,适度的激励可以显著提高采集率。这些结果可能有助于为未来涉及粪便采集的研究设计提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108c/9067695/cdf1aaf29a3b/pone.0267974.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108c/9067695/e96786a3130e/pone.0267974.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108c/9067695/cdf1aaf29a3b/pone.0267974.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108c/9067695/e96786a3130e/pone.0267974.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108c/9067695/cdf1aaf29a3b/pone.0267974.g002.jpg

相似文献

1
Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients.提高成人骨髓移植患者微生物组研究粪便收集率的经济激励措施。
PLoS One. 2022 May 4;17(5):e0267974. doi: 10.1371/journal.pone.0267974. eCollection 2022.
2
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.美国血液与骨髓移植学会、欧洲血液与骨髓移植学会、血液与骨髓移植临床试验网络以及国际骨髓瘤工作组关于复发多发性骨髓瘤患者挽救性造血细胞移植的共识会议
Biol Blood Marrow Transplant. 2015 Dec;21(12):2039-2051. doi: 10.1016/j.bbmt.2015.09.016. Epub 2015 Sep 30.
3
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.造血细胞移植合并症指数预测能力的前瞻性验证:一项国际血液和骨髓移植研究中心的研究
Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. doi: 10.1016/j.bbmt.2015.04.004. Epub 2015 Apr 7.
4
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.自体与减低强度异基因造血细胞移植治疗首次完全缓解或部分缓解后化疗敏感的滤泡性非霍奇金淋巴瘤患者。
Biol Blood Marrow Transplant. 2011 Jul;17(7):1051-7. doi: 10.1016/j.bbmt.2010.11.004. Epub 2010 Nov 10.
5
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.移植后环磷酰胺预防移植物抗宿主病的异基因造血细胞移植后,移植物冷冻保存不影响总体生存率。
Biol Blood Marrow Transplant. 2020 Jul;26(7):1312-1317. doi: 10.1016/j.bbmt.2020.04.001. Epub 2020 Apr 10.
6
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.一项生长抑素类似物帕瑞肽预防异基因造血干细胞移植中胃肠道毒性和急性移植物抗宿主病的 2 期临床试验。
PLoS One. 2021 Jun 25;16(6):e0252995. doi: 10.1371/journal.pone.0252995. eCollection 2021.
7
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.移植前抑郁对异基因和自体造血干细胞移植结局的影响。
Cancer. 2017 May 15;123(10):1828-1838. doi: 10.1002/cncr.30546. Epub 2017 Jan 19.
8
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.造血干细胞移植受者在移植后至少存活2年,其生存率在现代移植时代接近人群水平。
Biol Blood Marrow Transplant. 2020 Sep;26(9):1711-1718. doi: 10.1016/j.bbmt.2020.03.005. Epub 2020 Mar 16.
9
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
10
Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.外周 T/NK 细胞淋巴瘤中自体和异体造血细胞移植的争议。
Best Pract Res Clin Haematol. 2013 Mar;26(1):89-99. doi: 10.1016/j.beha.2013.04.008. Epub 2013 May 25.

本文引用的文献

1
Financial incentives for breast cancer screening undermine informed choice.乳腺癌筛查的经济激励措施会破坏知情选择。
BMJ. 2022 Jan 10;376:e065726. doi: 10.1136/bmj-2021-065726.
2
Ethical implications of recruiting universal stool donors for faecal microbiota transplantation.招募通用粪便供体进行粪便微生物群移植的伦理问题。
Lancet Infect Dis. 2020 Mar;20(3):e44-e49. doi: 10.1016/S1473-3099(19)30569-9. Epub 2019 Nov 26.
3
Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial.
经济激励措施对提高结直肠癌筛查参与度和减少差异的影响:一项随机临床试验。
JAMA Netw Open. 2019 Jul 3;2(7):e196570. doi: 10.1001/jamanetworkopen.2019.6570.
4
A Customized At-Home Stool Collection Protocol for Use in Microbiome Studies Conducted in Cancer Patient Populations.用于癌症患者人群中进行的微生物组研究的定制家庭粪便收集方案。
Microb Ecol. 2019 Nov;78(4):1030-1034. doi: 10.1007/s00248-019-01346-2. Epub 2019 Mar 30.
5
Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial.经济激励对邮寄结直肠癌筛查试验患者使用的影响:一项随机临床试验。
JAMA Netw Open. 2019 Mar 1;2(3):e191156. doi: 10.1001/jamanetworkopen.2019.1156.
6
Help, hope and hype: ethical considerations of human microbiome research and applications.帮助、希望与炒作:人类微生物组研究及应用的伦理考量
Protein Cell. 2018 May;9(5):404-415. doi: 10.1007/s13238-018-0537-4.
7
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.微生物组与造血细胞移植:过去、现在与未来
Biol Blood Marrow Transplant. 2018 Jul;24(7):1322-1340. doi: 10.1016/j.bbmt.2018.02.009. Epub 2018 Feb 19.
8
Successful collection of stool samples for microbiome analyses from a large community-based population of elderly men.从大量基于社区的老年男性群体中成功采集用于微生物组分析的粪便样本。
Contemp Clin Trials Commun. 2017 Sep;7:158-162. doi: 10.1016/j.conctc.2017.07.002. Epub 2017 Jul 6.
9
Active Choice and Financial Incentives to Increase Rates of Screening Colonoscopy-A Randomized Controlled Trial.增加结肠镜筛查率的主动选择和经济激励措施——一项随机对照试验
Gastroenterology. 2017 Nov;153(5):1227-1229.e2. doi: 10.1053/j.gastro.2017.07.015. Epub 2017 Jul 20.
10
The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.异基因造血细胞移植与移植物抗宿主病中的肠道微生物群
Blood. 2017 Feb 23;129(8):927-933. doi: 10.1182/blood-2016-09-691394. Epub 2016 Dec 9.